Dear Visitor!

Marcus Hacker

A very warm welcome to the website of the Division of Nuclear Medicine, Department of Biomedical Imaging and Image-giuded Therapy at the Medical University of Vienna. The Division of Nuclear Medicine at the General Hospital of Vienna is one of Europe's largest and most important nuclear medical departments with more than 90 staff, its room and equipment set up, the treatment ward incorporating 8 systemised beds as well as its radiochemistry/pharmacy with cyclotron facility.

In the area of imaging diagnostics all procedures of conventional nuclear medicine such as thyroid, skeleton, lung, brain and heart examinations as well as inflammation diagnostics in SPECT and SPECT/CT-Technology are offered.

In addition, the department has PET/CT and PET/MR scanners, which are used in combination with a wide range of radiopharmaceuticals for individual and customised diagnosis and therapy concepts. This is of crucial importance for the close cooperation with the Comprehensive Cancer Center (CCC) and the numerous university hospitals.

The department further focuses on nuclear medicine treatments of thyroids, liver, prostate or neuroendocrine tumours using beta and alpha radiation emitters.

We look forward to being able to welcome you to our department and want to make your stay as pleasant as possible.

 

Univ.-Prof. Dr. med. Marcus Hacker
head of the division of Nuclear Medicine

Events

 

Aufgrund der aktuellen Coronavirus SARS-CoV2 (COVID-19) Pandemie finden aktuelle sowie in naher Zukunft geplante nationale und internationale sowie interne Veranstaltungen der Klinischen Abteilung für Nuklearmedizin nicht statt.

 
 

News

 
   

Neue Publikation in der Fachzeitschrift Circulation der AHA

 
 

Der FWF hat neue Fachreferent*innen in das Kuratorium gewählt.

 
 

Trotz der intensiven Forschung der letzten Jahrzehnte ist die Ursache der meisten neurodegenerativen Erkrankungen ungeklärt, wodurch eine gezielte Behandlung erschwert wird. Ausgehend von einem psychoaktiven Inhaltsstoff der in Asien als Rauschdroge verwendeten Betelnuss, entwickelten Radiochemiker*

 
 

Etablierung und erste Erfahrungen eines neuen [18F]FDG PET/MR Protokolls mit indirekter absoluter [18F]FDG Quantifizierung für Patienten mit nicht-läsioneller Epilepsie

 
 

Neue Erkenntnisse einer Nierenfunktionstherapie wurden im Journal "Diabetes Research & Care" veröffentlicht.

 
 
 
 

Featured